Works matching IS 2076393X AND DT 2024 AND VI 12 AND IP 2
Results: 109
Quantitative Analysis of the Instant and Persistent Inhibition Effects of Maternal Poliovirus Antibodies on the Immune Response in a Phase IV Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 217, doi. 10.3390/vaccines12020217
- By:
- Publication type:
- Article
Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 216, doi. 10.3390/vaccines12020216
- By:
- Publication type:
- Article
The Chimeric Chaoyang-Zika Vaccine Candidate Is Safe and Protective in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 215, doi. 10.3390/vaccines12020215
- By:
- Publication type:
- Article
Impaired IgM Memory B Cell Function Is Common in Coeliac Disease but Conjugate Pneumococcal Vaccination Induces Robust Protective Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 214, doi. 10.3390/vaccines12020214
- By:
- Publication type:
- Article
Bacterial Vaccinations in Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 213, doi. 10.3390/vaccines12020213
- By:
- Publication type:
- Article
Porcine Epidemic Diarrhea: Insights and Progress on Vaccines.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 212, doi. 10.3390/vaccines12020212
- By:
- Publication type:
- Article
Vaccine Effectiveness against SARS-CoV-2 Infection during the Circulation of Alpha, Delta, or Omicron Variants: A Retrospective Cohort Study in a Tertiary Hospital in Serbia.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 211, doi. 10.3390/vaccines12020211
- By:
- Publication type:
- Article
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 210, doi. 10.3390/vaccines12020210
- By:
- Publication type:
- Article
Serum SARM1 Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: Correlation with Clinical Neuropathy Scales and Nerve Conduction Studies and Impact of COVID-19 vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 209, doi. 10.3390/vaccines12020209
- By:
- Publication type:
- Article
IgG Subclass Switch in Volunteers Repeatedly Immunized with the Full-Length Plasmodium falciparum Merozoite Surface Protein 1 (MSP1).
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 208, doi. 10.3390/vaccines12020208
- By:
- Publication type:
- Article
A Polyclonal Antibody against a Burkholderia cenocepacia OmpA-like Protein Strongly Impairs Pseudomonas aeruginosa and B. multivorans Virulence.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 207, doi. 10.3390/vaccines12020207
- By:
- Publication type:
- Article
Immunity from NK Cell Subsets Is Important for Vaccine-Mediated Protection in HPV+ Cancers.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 206, doi. 10.3390/vaccines12020206
- By:
- Publication type:
- Article
Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in Italy.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 205, doi. 10.3390/vaccines12020205
- By:
- Publication type:
- Article
The Shifting Epidemiology of Hepatitis A in the World Health Organization Western Pacific Region.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 204, doi. 10.3390/vaccines12020204
- By:
- Publication type:
- Article
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 203, doi. 10.3390/vaccines12020203
- By:
- Publication type:
- Article
Safety and Tolerability of COVID-19 Vaccine in Mast Cell Disorders Real-Life Data from a Single Centre in Italy.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 202, doi. 10.3390/vaccines12020202
- By:
- Publication type:
- Article
A Practical Guide to Full Value of Vaccine Assessments.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 201, doi. 10.3390/vaccines12020201
- By:
- Publication type:
- Article
Edible Plant-Derived Extracellular Vesicles for Oral mRNA Vaccine Delivery.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 200, doi. 10.3390/vaccines12020200
- By:
- Publication type:
- Article
Immune Response to COVID-19 Vaccination in Frontline Healthcare Workers.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 199, doi. 10.3390/vaccines12020199
- By:
- Publication type:
- Article
Polymeric Nanoparticles as Oral and Intranasal Peptide Vaccine Delivery Systems: The Role of Shape and Conjugation.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 198, doi. 10.3390/vaccines12020198
- By:
- Publication type:
- Article
Advancements in Vaccine Strategies for Chronic Liver Disease Patients: Navigating Post-COVID Challenges and Opportunities.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 197, doi. 10.3390/vaccines12020197
- By:
- Publication type:
- Article
Key Learnings from the Development and Early Use of Global Guidance on the Integration of COVID-19 Vaccination into Broader Health Systems.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 196, doi. 10.3390/vaccines12020196
- By:
- Publication type:
- Article
Measuring Zero-Dose Children: Reflections on Age Cohort Flexibilities for Targeted Immunization Surveys at the Local Level.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 195, doi. 10.3390/vaccines12020195
- By:
- Publication type:
- Article
Fatal Myocarditis following COVID-19 mRNA Immunization: A Case Report and Differential Diagnosis Review.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 194, doi. 10.3390/vaccines12020194
- By:
- Publication type:
- Article
Assessing a Digital Scorecard on Global Immunization Progress: Stakeholder Views and Implications for Enhancing Performance and Accountability.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 193, doi. 10.3390/vaccines12020193
- By:
- Publication type:
- Article
Influenza Vaccination in Children Younger than 5 Years in the Region of Murcia (Spain), a Comparative Analysis among Vaccinating and Non-Vaccinating Parents: Data from the FLUTETRA Study.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 192, doi. 10.3390/vaccines12020192
- By:
- Publication type:
- Article
Vaccine Strategies to Elicit Mucosal Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 191, doi. 10.3390/vaccines12020191
- By:
- Publication type:
- Article
Intradermal Inoculation of Inactivated Foot-and-Mouth Disease Vaccine Induced Effective Immune Responses Comparable to Conventional Intramuscular Injection in Pigs.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 190, doi. 10.3390/vaccines12020190
- By:
- Publication type:
- Article
Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 189, doi. 10.3390/vaccines12020189
- By:
- Publication type:
- Article
COVID-19 Vaccine Coverage and Factors Associated with Vaccine Hesitancy: A Cross-Sectional Survey in the City of Kinshasa, Democratic Republic of Congo.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 188, doi. 10.3390/vaccines12020188
- By:
- Publication type:
- Article
Human Papillomavirus (HPV) Vaccine Coverage and Confidence in Italy: A Nationwide Cross-Sectional Study, the OBVIOUS Project.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 187, doi. 10.3390/vaccines12020187
- By:
- Publication type:
- Article
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 186, doi. 10.3390/vaccines12020186
- By:
- Publication type:
- Article
Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 185, doi. 10.3390/vaccines12020185
- By:
- Publication type:
- Article
Sustainable Dengue Prevention and Management: Integrating Dengue Vaccination Strategies with Population Perspectives.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 184, doi. 10.3390/vaccines12020184
- By:
- Publication type:
- Article
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 183, doi. 10.3390/vaccines12020183
- By:
- Publication type:
- Article
The Dynamic Risk of COVID-19-Related Events in Vaccinated Healthcare Workers (HCWs) from a Tertiary Hospital in Bucharest, Romania: A Study Based on Active Surveillance Data.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 182, doi. 10.3390/vaccines12020182
- By:
- Publication type:
- Article
Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 181, doi. 10.3390/vaccines12020181
- By:
- Publication type:
- Article
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 180, doi. 10.3390/vaccines12020180
- By:
- Publication type:
- Article
Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 179, doi. 10.3390/vaccines12020179
- By:
- Publication type:
- Article
Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 178, doi. 10.3390/vaccines12020178
- By:
- Publication type:
- Article
COVID-19 Vaccinations, Trust, and Vaccination Decisions within the Refugee Community of Calgary, Canada.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 177, doi. 10.3390/vaccines12020177
- By:
- Publication type:
- Article
Vaccine Hesitancy and Public Mistrust during Pandemic Decline: Findings from 2021 and 2023 Cross-Sectional Surveys in Northern Italy.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 176, doi. 10.3390/vaccines12020176
- By:
- Publication type:
- Article
Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 175, doi. 10.3390/vaccines12020175
- By:
- Publication type:
- Article
Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 174, doi. 10.3390/vaccines12020174
- By:
- Publication type:
- Article
Effectiveness of Influenza Vaccination and Early Antiviral Treatment in Reducing Pneumonia Risk in Severe Influenza Cases.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 173, doi. 10.3390/vaccines12020173
- By:
- Publication type:
- Article
MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 172, doi. 10.3390/vaccines12020172
- By:
- Publication type:
- Article
"Every Time It Comes Time for Another Shot, It's a Re-Evaluation": A Qualitative Study of Intent to Receive COVID-19 Boosters among Parents Who Were Hesitant Adopters of the COVID-19 Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 171, doi. 10.3390/vaccines12020171
- By:
- Publication type:
- Article
Intussusception and Other Adverse Event Surveillance after Pilot Introduction of Rotavirus Vaccine in Nam Dinh and Thua Thien Hue Provinces—Vietnam, 2017–2021.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 170, doi. 10.3390/vaccines12020170
- By:
- Publication type:
- Article
Correlating Stability-Indicating Biochemical and Biophysical Characteristics with In Vitro Cell Potency in mRNA LNP Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 169, doi. 10.3390/vaccines12020169
- By:
- Publication type:
- Article
Status of Routine Immunization Coverage in the World Health Organization African Region Three Years into the COVID-19 Pandemic.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 168, doi. 10.3390/vaccines12020168
- By:
- Publication type:
- Article